The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Keywords

Medicine, Disease burden, Environmental health, Years of potential life lost, Absenteeism

References

• A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.Mitchell R. Wenger, Rick Elam, Kelly L. Williams — 1994
• The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality.Verena Menec, Charlyn Black, Leonard MacWilliam — 2003
• Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.Robert B. Belshe, William C. Gruber — 2001
• Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates.Robert N. Anderson, Arialdi Miniño, Donna L. Hoyert — 2001
• Prevention effectiveness : a guide to decision analysis and economic evaluationAnne C. Haddix — 1996
• National hospital discharge survey.B. S. Gillum — 2004
• Health care utilization and expenditures in the United States: a study of osteoporosis-related fracturesLucinda Orsini, Matthew D. Rousculp, Stacey R. Long — 2005
• An intranasal influenza vaccine for the prevention of influenza in healthy children was cost effectiveBenjamin Schwartz — 2002
• Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of ChildrenLisa A. Prosser, Carolyn B. Bridges, Timothy M. Uyeki — 2006
• Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.Carolyn B. Bridges, W. Thompson, Martin I. Meltzer — 2000
• Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.Wendy A. Keitel, Thomas R. Cate, R. B. Couch — 1997
• Science and Judgement in Risk AssessmentG Diggle — 1995
• Strengthening the nation's influenza vaccination system: a National Vaccine Advisory Committee assessment.Charles M. Helms, Fernando Guerra, Jerome O. Klein — 2005
• Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.W.E.P. Beyer, A.M. Palache, J.C. de Jong — 2002
• Access to orthopedic care for children with medicaid versus private insurance in California.David L. Skaggs, Samantha M. Clemens, Michael G. Vitale — 2001
• Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts.Eugene S. Hurwitz — 2000
• Influenza-associated hospitalizations in the United States.W. Thompson — 2004
• Altruistic and private valuations of risk reductionW. Kip Viscusi, Wesley A. Magat, Anne Forrest — 1988
• Influenza and the rates of hospitalization for respiratory disease among infants and young children.Héctor S. Izurieta, W. Thompson, Piotr Kramarz — 2000
• Influenza Vaccine Confusion: A Call for an Alternative Evidence-Based ApproachRam Yogev — 2005

Cited by

• Valutazione economica del vaccino antinfluenzale adiuvato con virosomi in Italia nella popolazione anzianaRoberto Gasparini, Carlo Lucioni, S. Mazzi — 2013
• Killer T cells in influenza.María Pilar Abad García — 2008
• Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccinationÁlvaro Revilla, Y. Escamilla, Miguel A. Romera — 2008
• Incidence, Seasonality and Mortality Associated with Influenza Pneumonia in Thailand: 2005–2008Pier Cesare Rivoltella — 2009
• Recommendation for Mandatory Influenza Immunization of All Health Care PersonnelВрублевская Оксана Алексеевна — 2010
• Preliminary results of 2009 pandemic influenza surveillance in the United States using the Aggregate Hospitalization and Death Reporting Activity明 松本 — 2011
• Adolescent Immunization UpdateLalie Douglas — 2011
• Excess mortality in Europe following a future Laki-style Icelandic eruptionJosep Segura i Salado — 2011
• Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial.Eleanor Carol Bennett, Marvin Weisinger — 2012
• Species-Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 ProteinAdelina Méndez de la Torre — 2012
• Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11).Jolita Mereckiene, Suzanne Cotter, A Nicoll — 2014
• Memory CD4 T cells in InfluenzaSusan Matulevicius, Anand Rohatgi, Amit V. Khera — 2015
• Prevention and management of influenza in pregnancy.Robert S. Jordan, Adrian Müller, Anne Oudes — 2014
• Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase誠 福田, 孝泰 酒井, 達雄 酒井 — 2015
• Economics of Influenza Vaccine Administration Timing for ChildrenBruce Y. Lee, Julie Tai-Schmiedel, Rachel R. Bailey — 2010
• Vaccination Rates Are Associated with Functional Proximity but Not Base Proximity of Vaccination ClinicsJosé Antonio Otero Hermida, Juliana Villasante, Gumersindo Lena López — 2016
• Dynamic modelling approaches for the analysis of the cost-effectiveness of seasonal influenza controlH. Bied-Charreton — 2017
• Model estimates of the burden of outpatient visits attributable to influenza in the United StatesOnieva Espejo, M. Asunción — 2016
• Interactions Between NS1 of Influenza A Viruses and Interferon-α/β: Determinants for Vaccine DevelopmentBen X. Wang, Eleanor N. Fish — 2017
• Immune FunctionIrene Boned Segarra — 2016

Related papers

• Infant mortality and average life expectancy.Z Zhai — 1986
• The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015Liliana G Ciobanu, Alize J Ferrari, Holly E Erskine — 2018
• The prevalence and burden of mental and substance use disorders in Romania: Findings from the Global Burden of Disease Study 2016.Mihai-Bogdan Iovu, Maria Alina Breaz — 2019
• The Burden of Disease in Germany at the National and Regional Level-Results in Terms of Disability-Adjusted Life Years (DALY) from the BURDEN 2020 Study.Michael Porst, Elena von der Lippe, Janko Leddin — 2022
• Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017Marcela Agudelo‐Botero, Rafael Valdez-Ortiz, Liliana Giraldo‐Rodríguez — 2020
• Burden of diabetes mellitus attributable to demographic levels in Qatar: an emerging public health problem.Abdülbari Bener, Eun Jung Kim, Fatih Mutlu — 2014
• Traumatic Brain Injury in the Netherlands: Incidence, Costs and Disability-Adjusted Life YearsAnnemieke C. Scholten, Juanita A. Haagsma, M.J.M. Panneman — 2014
• БРЕМЯ БОЛЕЗНИ И УТРАЧЕННЫЙ ЖИЗНЕННЫЙ ПОТЕНЦИАЛ НАСЕЛЕНИЯ ВСЛЕДСТВИЕ ВИЧ-ИНФЕКЦИИА. И. Блох, О. А. Пасечник — 2017